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Autoimmunity refers to the system of immune responses in
which immune cells and involved proteins in this system
attack their cells and tissues [1]. Causes of autoimmunity
are complex and sometimes unknown but generally, the
genetic susceptibility and presence of environmental risk
factors can play a role in the development of autoimmunity
[1]. Growing incidence of these diseases has attracted
much attention. Type 1 diabetes is a cell-mediated auto-
immune disease [2] in which pancreatic islet beta cells are
destroyed [2e4]. This autoimmune disease is due to the
combination of various genetic and environmental factors
[5]. In the recent years, having determined genetic factors
involved in the development of type 1 diabetes [6,7], ef-
forts have sought to determine the environmental factors
of this disease.
Viruses are considered the main environmental causes
of autoimmune diseases [8]. Among the viral families,
enteroviruses are considered to be involved in the path-
ogenesis of type 1 diabetes [9,10], although the mecha-
nism(s) of pathogenicity of these viruses has (have) not
yet been sufficiently understood. Iran has a low rate of
type 1 diabetes incidence (3.7 per 100,000 people) [11],
but the frequency of enteroviral infection in type 1 dia-
betes patients, and their potential effects on the immune
system have not been adequately studied in this country.
In this study, we investigated enteroviruses genome in
peripheral blood mononuclear cells (PBMCs) using a sen-
sitive assay, RT-PCR, and the primers for 50-untranslated
region which are shared by all enteroviruses, to determine
the prevalence of infection in Iranian patients with type 1
diabetes.
Previous studies suggested that imbalance in the pop-
ulation of naive, effector and memory lymphocyte subsets
could cause autoimmune diseases [12]. It has been shown
that enteroviral infections mainly have an immunomodu-
latory effect and, in rare cases, directly lyse beta cells
[5,13]; in other words, these viruses serve as immune
modifiers, not just simple triggers. Therefore, we evalu-
ated the potential effects of enterovirus on the distribu-
tion of T CD8þ lymphocyte, as main cells involved in the
destruction of the beta islet cells, and its subsets in type 1
diabetes patients. First, we looked for the presence of
enteroviral infection in patients with diabetes. In the next
step, the patient group was divided into two groups con-
sisting of the enterovirus-infected group and non-
enterovirus-infected group. Then, we investigated alter-
ation in the distribution of T CD8þ lymphocytes population
and their subsets in these groups compared with a control
group.
Materials and methods
Patients and clinical specimens
In this caseecontrol study, samples were taken from 35
patients with type 1 diabetes aged 2e27 [mean: 13.7  6.6]
years. The patients were followed up by the Department of
Internal Medicine of the Shahrekord University of Medical
Sciences. After research purposes were explained, thepeople who volunteered to participate in the study pro-
vided informed consent for their voluntary participation. In
case of collecting samples from under 18 years-old patients
and volunteers, we gained informed consents from their
parents or legal guardian after explanations the aims of the
research. It should be noted that patients were selected
based on their diagnostic criteria by a specialist for this
study. We did not sample from diabetic patients with any
autoimmune background in their family since we wanted to
study on enteroviruses, as an external factor involved in
type 1 diabetes diseases, and their probable function on
alteration of CTLs subsets.
Then, suitable samples were taken from the patients.
Moreover, appropriate samples of 35 healthy people (1e27
(mean: 13.6  7.3) years), who were age and sex-matched
with patients, were taken in the same year with controls.
The serum samples were kept at 80 C until assays with
anti-enterovirus VP1 protein and autoantibody ELISA kits.
RNA was extracted immediately from a portion of freshly
PBMCs for RT-PCR enterovirus genome detection. Another
part of the collected PBMCs was used to identify pheno-
types of T CD8þ subsets using flow cytometry.
RNA extraction and RT-PCR
PBMCs of the patients and controls were isolated from
whole blood by Ficoll density gradient centrifugation. We
extracted total RNA from PMBCs using QIAamp Viral RNA
Mini Kit (QIAGEN, Germany) according to the manufac-
turer’s instructions. Total RNA was transferred immediately
to and kept in a freezer at 80 C till cDNA synthesis. cDNA
was synthesized with reverse transcriptase kit (Takara,
Japan).
Two ml PrimeScript Buffer 5X (containing MgCl2 and
dNTP), 0.5 ml PrimeScript RT Enzyme Mix I (containing
RNase Inhibitor), 50 pmol Random Hexamer, 1 pmol Gene-
specific primer F1: 50-CACCGGATGGCCAATCCA-30, and
1.5 ml nuclease free water were added to 5 ml extracted
total RNA. This mixture was incubated for 15 min at 42 C in
one cycle for reverse transcription. Then, it was incubated
for 5 s at 85 C for inactivation of reverse transcriptase with
heat treatment.
Produced cDNA was used for amplification in nested RT-
PCR. We used two-step RT-PCR to detect enteroviral RNA.
At the first step, 22.5 ml master mix solution containing
0.5 ml F1 primer, 0.5 ml R1 primer: 50-CCTCCGGCC
CCTGAATG-30 [9], ready-to-use PCR Buffer (containing
TriseHCl, NH4SO4, EDTA and 2-mercaptoethanol in
pH Z 8.8), 0.5 ml MgCl2, 0.5 ml dNTP, 0.1 ml Taq DNA po-
lymerase 1.2 U and 17.9 ml nuclease-free water was added
to 2.5 ml cDNA. The first step of PCR was performed on a
total volume of 25 ml of the mixture in the following ther-
mal cycle program: At the first step, we performed initial
denaturation at 94 C for 5 min. Then, five cycles were
conducted at 90 C for 30 s, 59 C for 25 s and 73 C for 40 s.
These five cycles were followed by 30 cycles in the
following thermal cycle program: 94 C for 45 s, 57.7 C for
25 s and 73 C for 45 s. At the end of the first step of PCR, a
final extension was conducted at 73 C for 10 min.
In the second step of the nested-PCR test, 1.6 ml of the
first PCR product was diluted at a ratio of 1:20 by nuclease
free water. Two and a half ml diluted DNA was mixed in the
276 O. Zargari Samani et al.total of 22.5 ml prepared PCR master mix but with the
change in primers to F2: 50-ATTGTCACCATAAGCAGCCA-30
and M13-R2: 50-TATGTAAAACGACGGCCAGT-GCCCCTGAAT
GCGGCTAAT-30 (Table 1). Nested-PCR was performed in a
similar manner to the first step, but 30 cycles in nested-PCR
were followed in new annealing temperature (at 60 C).
M13-primer was used to sequence PCR products (the data of
sequencing are not shown). PCR products were electro-
phoresed on 1.5% agarose gel (Sigma, Germany) and
ethidium bromide used for staining bands. In the first step,
197-bp products were synthesized, and in the nested-PCR,
the final product was 165-bp.
Anti-VP1 antibody and autoantibody to GAD65
Anti-VP1 antibodies of three different classes (IgA, IgG, and
IgM) were measured in the patients’ and controls’ serum
samples by an ELISA kit (Serion/Virion, Germany). In addi-
tion, antibodies against GAD65 were measured by GAD65-
Ab ELISA kit (BIOMERICA, USA).
Analysis of immunological markers of cytotoxic
lymphocytes
PBMCs were isolated by Ficoll density gradient centrifuga-
tion from freshly heparinized blood and washed twice in
PBS solution. Approximately 105 PBMCs were collected from
each sample. The cells were collected in separated tubes.
The antibody which was used to identify cytotoxic
lymphocyte cells was anti-CD8 conjugated with PE-Cy5
(Becton Dickinson, UK). To further distinguish cytotoxic
lymphocytes subsets, anti-CD45RO conjugated with phyco-
erythrin and anti-CD45RA conjugated with fluorescein iso-
thiocyanate (FITC) (Becton Dickinson, UK) were added to
each tube. The PBMCs in the tubes alongside sufficient
amounts of these monoclonal antibodies were incubated
for 20 min at 4 C, and then 20 min at room temperature.
After staining tubes, to remove extra and unbounded
conjugated antibodies, cells in the tubes were washed
twice with PBS. The phenotypes of the cells were analyzed
by three-color Partec CyFlow Space flow cytometer (Partec
GmbH, Germany). At least 10.000 cells were counted and
analyzed per each sample. Analysis of naive, effector and
memory CD markers of the cytotoxic lymphocytes was
performed by Flowjo software. We also gated population of
lymphocytes to calculate more accurate percentages of
lymphocytes and their subsets based on respective anti-
bodies. By this gating, we did not count the monocytes,Table 1 Some characteristics of nested-PCR primers used
Primers Sequence Te
R1 50-CACCGGATGGCCAATCCA-30 59
F1 50-CCTCCGGCCCCTGAATG-30 59
M13-R2 50-TATGTAAAACGACGGCCAGT-
GCCCCTGAATGCGGCTAAT-30
60
F2 50-ATTGTCACCATAAGCAGCCA-30 57
a Regardless of M13-primer.remaining red blood cells, granulocytes, dead cells and
other debris. The percentage of positive cells was deter-
mined by setting the lower limit line over the non-specific
fluorescence of unstained samples and samples with suit-
able isotype control.
Statistical analysis
The flow cytometric findings are expressed as means  SD.
The percentages of cytotoxic T lymphocytes and their
subsets in the two groups of the patients and the controls
were compared by two-tailed student’s t-test for unpaired
samples with the normal distribution. The results of ELISA
on detection of antibodies and autoantibodies were
compared by Fisher’s exact test, and those of nested-PCR
were compared among the groups by chi-square test. Sta-
tistical analysis was conducted by SPSS 23.0. P value less
than 0.05 was considered the level of significance.
Results
ELISA
Antibodies against GAD65 were detected in 10 (28.5%) of
the 35 patients with type 1 diabetes, and 1 (2.8%) of the 35
controls (P Z 0.003). Furthermore, anti-GAD65 antibody
titer was significantly higher in enterovirus-infected pa-
tients with type 1 diabetes than in the non-enterovirus-
infected patients and controls (P Z 0.001 and P < 0.001,
respectively).
Anti-EV VP1-IgA antibodies were detected in the serum
of 10 (28.5%) patients and anti-EV VP1 IgG antibodies in 13
(37.1%) of 35 patients. Moreover, we found no anti-EV VP1-
IgM antibodies in the patients’ serum. Anti-EV VP1-IgM an-
tibodies were not measured in the serum samples of the
controls.
Nested-PCR
As we can see in Figure 1, the Nested-PCR was positive in 12
(34.3%) of 35 patients with type 1 diabetes, and only 1
(2.9%) of 35 the controls with a significant difference be-
tween the two groups of the patients and the controls
(P Z 0.001).
Generally, anti GAD65, as an autoantibody, can observe
in the control subjects. It is also true in terms of positive
PCR result [9]. So we did not omit the data of autoantibody
and PCR positive healthy subjects in statistical analysis.in the study.
mperature (C) Location Product size
.7 645e628 197-bp
.4 448e464
.5a 450e468 165-bp
.4 596e577
Figure 1. The results of nested-PCR in patients with type 1
diabetes; Pt: Patient; Neg: Negative control; Pos: Positive
control; and L: DNA Ladder (Fermentas 50bp-Ladder, USA).
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Analysis of flow cytometry plots (Figure 2) showed that the
percentage of CD8þ T cells was significantly higher in pa-
tients with diabetes than in the controls (24.7  4.2% vs.Figure 2. Three-color flow cytometry, histogram analysis of hum
color PE-Cy5; the CD8þ cells; B. The second filter, color PE; the CD
fluorescein isothiocyanate, the CD8þ CD45RAþ or naive cytotoxic c
cytotoxic cell subsets on isolated PBMCs after compensation proces
memory and effector (CD8þ CD45RAþCD45ROþ) cytotoxic subsets. T
and effector subsets were measured in the enterovirus-infected a
healthy controls.21.4  5.1%, PZ 0.007) (Table 2). However, CD8 frequency
was not significantly different between enterovirus-
infected and non-enterovirus-infected patients with type
1 diabetes (P > 0.05). The results obtained from experi-
ments on CD8þ cytotoxic lymphocyte subsets are as follows:
The percentage of CD8þ CD45RAþ lymphocytes increased in
both infected and non-infected patients compared to the
controls (24.6  3.9% and 21.4  3.2% vs. 18.2  5.5%,
P < 0.001 and P Z 0.012, respectively) with no significant
difference between the two groups of the patients.
We did not observe alterations of the CD8þ memory
subset in the studied groups. The percentage of CD8þ
CD45ROþ lymphocytes was not significantly different
among enterovirus-infected patients, non-enterovirus-
infected patients, and the controls (7.6  1.8% and
8.0  3.3% vs. 7.2  2.0%, respectively, P > 0.05). The
percentage of cytotoxic effector lymphocytes or CD8þ
CD45RAþCD45ROþ lymphocytes, which co-express naive
and memory markers and are the most important cells
involved in type 1 diabetes pathogenesis and islet beta cells
destruction, decreased very significantly in type 1 diabetican cytotoxic lymphocytes and their subsets; A. The third filter,
8þ CD45ROþ or memory cytotoxic cells; C. The first filter, color
ells; and D. dot plot, determination of the distribution of each
s and CD8 gating on FL1 and FL2 filters for measuring the naive,
he percentages of the cytotoxic cells and their naive, memory
nd non-enterovirus-infected patients with type 1 diabetes and
Table 2 Distribution of cytotoxic T lymphocytes (CTLs) and their subsets in enterovirus-infected and non-enterovirus-infected
patients with type 1 diabetes and healthy controls.
Percentage Diabetic patients Healthy controls
CD8þ (CTLs) 24.7 (4.2)z 21.4 (5.1)
Enterovirus-infected
patients with type 1 diabetes
Non-enterovirus-infected
patients with type 1 diabetes
Healthy controls
CD8þ CD45RAþ (Naive) 24.6 (3.9)yz 21.4 (3.2)y 18.2 (5.5)
CD8þ CD45ROþ (Memory) 7.6 (1.8) 8.0 (3.3) 7.2 (2.0)
CD8þ CD45RAþ ROþ (Effector) 21.0 (3.9)z* 24.6 (4.3) 25.6 (4.4)
The percentage is reported as mean (SD); subsets are given as a percentage of the CTLs in peripheral blood. yP < 0.05 vs. healthy
controls. zP < 0.01 vs. healthy controls. yzP < 0.001 vs. healthy controls. *P < 0.05 vs. non-enterovirus-infected patients with type 1
diabetes.
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trols (21.0  3.9% vs. 25.6  4.4%, PZ 0.002). Non-infected
type 1 diabetic patients also had a decrease in the per-
centage of cytotoxic effector lymphocytes compared to
controls, but this decrease was not significant (24.6  4.3%
vs. 25.6  4.4%, P Z 0.299).
All in all, our findings in the present study showed that
the prevalence of enteroviral infection in people who
developed type 1 diabetes after 10 years of age was
significantly higher than those developing diabetes before
this age (Table 3). Also our results showed that enteroviral
infection was not associated with sex (P Z 0.689).
Enteroviral infection in people who developed type 1 dia-
betes after 10 years of age was significantly higher than
those developing type 1 diabetes at younger ages
(P Z 0.030).Discussion
Autoimmune diseases, such as type 1 diabetes, result from
the combination of environmental factors and genetic sus-
ceptibility. Environmental agents along with genetic factors
predispose a person to type 1 diabetes. Therefore, any
changes in environmental factors in genetically susceptible
people may be considered a strategy to prevent the
development of type 1 diabetes [4]. Investigation of these
factors can expand our understanding of this disease and
lead to new methods to predict the risk of developing type 1
diabetes, preventing it, or slowing down its progression.Table 3 The demographic characteristics of patients with type
Number Age
(mean  SD)
Range of age
(years)
Sex
Male/Fem
Patients group 35 13.6(7.3) 2e27 13/22
Control group 35 13.75(6.0) 1e27 17/18
Enteroviruses
Age at diabetes onset Positive Nested-PCR
Under 10 years old 5a
Over 10 years old 7b
a Three male patients and two female patients.
b Two male patients and five female patients.Moreover, to investigate the possible relationship be-
tween enteroviral infection, as an important environmental
factor, and development of type 1 diabetes among Iranian
patients, we investigated immunological phenotypic alter-
ation in CD8þ T cells with emphasis on the possible role of
enteroviruses. Such studies about CTLs subsets alteration in
patients with type 1 diabetes, enterovirus-infected pa-
tients, in particular, have not conducted yet. Currently, the
risk of type 1 diabetes development is assessed by detec-
tion of antibodies against pancreatic autoantigens in pre-
diabetes people [4,9]. GAD65 is considered as the main
autoantigen in type 1 diabetes so that the presence of
antibodies against this autoantigen precedes the disease
[9], although the absence of anti-GAD65 antibody does not
necessarily represent no risk of type 1 diabetes.
Therefore, alongside detection of antibodies against
GAD65 autoantigen, other factors may be measured to
predict better the risk of developing type 1diabetes. CD8þ
T cells are, on the one hand, the main cells causing cell-
mediated autoimmune responses and, one the other
hand, are involved in fighting the viruses. These cells are
functionally divided into three subsets: naive, effector and
memory cells [2,12]. According to Bossowski et al.’s study,
any changes in the distribution of these cells result in
autoimmunity [14]. Viruses and autoantigens may cause
such alterations in the balance of their cells and therefore
investigation of this issue was one of the aims of this study.
According to the flow cytometric results, we observed a
decrease in CD8þ CD45ROþCD45RAþ population in periph-
eral blood of enterovirus-infected patients. This decrease1 diabetes and healthy controls.
ale
anti-VP1 IgA anti-VP1 IgG anti-VP1 IgM Positive
Nested-PCR
Male/Female
10 13 0 5/7
2 2 e 1/0
Negative Nested-PCR Total
18 23
5 12
An alarming factor for type 1 diabetes mellitus 279in cytotoxic effector cells can be interpreted concerning
Graham et al.’s and Faustman’s findings [15,16].
This active subset for performing cytotoxic functions and
triggering other actions of the cells, such as macrophages,
re-migrates to the islets [15]. Thus, the population of this
subset naturally decreases in peripheral blood. Significant
increase in naı¨ve CD8þ subset in both (enterovirus-infected
and non-enterovirus-infected) groups of patients with type
1 diabetes compared to the controls, and also lack of any
change in percentage of memory cytotoxic subset in all
groups, showed that differentiation of naive cytotoxic T
subset into memory one was blocked in the patients,
especially enterovirus-infected group. Besides that, we
observed an increase in cytotoxic T cell population in the
patients. Taken together, it can be hypothesized that
blocking of differentiation pathway to memory subsets
causes excess accumulation in the population of effector
cytotoxic T subsets in the patients. Because of migration of
effector CTLs to the pancreas via the circulation, it is
obvious that increase in the number of these subsets is not
detectable in peripheral blood. This possible mechanism
can exacerbate beta cells destruction and cause the
development of type 1 diabetes.
Enteroviruses formed dsRNA to develop a persistent
infection [13,17]. This causes lasting immune response and
probably phenotypic changes in enterovirus-infected pa-
tients with diabetes. Enteroviruses are likely to block
differentiation of naive cytotoxic subset to the memory
cells through certain molecular mechanisms and to trigger
or enhance effector subsets immigration to pancreas
where they lyse beta cells [13]. As a result, the distribution
of cytotoxic subsets is disrupted and therefore the disease
is developed. Based on the findings in this study, the titer
of anti-GAD65 is significantly higher in enterovirus-
infected patients with type 1 diabetes than in non-
enterovirus-infected patients. Previous studies showed
that enterovirus-infected people could produce antiviral
responses which cross-reacted with beta cell self-antigens
by a mechanism called molecular mimicry [9,13,18]. The
results of this study can be explained in the light of ho-
mology between the 2C protein in VP1 antigen of entero-
viruses and pancreatic GAD protein [9,13]. Because of this
similarity between the antigens and molecular mimicry
mechanisms, enterovirus-infected people are likely to
have higher GAD65 antibodies titers than non-enterovirus-
infected and healthy people. Regarding that IgG to
enterovirus VP1 protein in the serum of people with type 1
diabetes remains for many years [19], this antibody may be
considered a better indicator of the incidence of entero-
viral infection. Atkinson and Eisenbarth’s study showed
that the highest incidence of type 1 diabetes usually oc-
curs before 10 years of age [6]. Similarly, based on our
results in Table 3, if someone was already infected with
enteroviruses in the first years of life, the risk of devel-
oping diabetes reduced. It can be argued that most prob-
ably, genetic factors play a role in type 1 diabetes in the
early years of life (before 10 years of age) and then, the
role of environmental factors, especially enteroviruses,
becomes more prominent.
Therefore, age can play an important part in the
detection of susceptible people. The results of this study
indicated that the prevalence of enteroviral infection inpeople with type 1 diabetes (34.2%) was significantly higher
than in the controls, which is consistent with Kawashima
et al.’s study conducted in Japan [9]. The incidence rate of
enteroviral infection in patients with type 1 diabetes in this
study is higher than those reported by the studies con-
ducted in some European countries [20e22] and Cuba [19].
The issue becomes more complicated when genetic,
immunological and viral factors are simultaneously consid-
ered. Certainly, genetic and environmental factors are
intertwined in the onset of type 1 diabetes. The most
important genes involved in the development of type 1
diabetes are located on the short arm of chromosome 6
[1,5]. This gene region contains HLA class I and class II loci.
Investigating the polymorphisms of HLA class I genes, as
molecules, that present self and viral peptides to CTLs, has
demonstrated that HLA-A*0201 is responsible for presenting
GAD peptides and enteroviral 2C proteins [2]. The molec-
ular mimicry mechanism in people who have this allele of
HLA, especially if it is associated with HLA-DR4, is likely to
cause infiltration of the effector CTL subset and develop-
ment of the disease in pancreatic phase. The cytotoxic
effector cells have been found to produce IFN-g [23]. Local
IFN-g produced by these cells and CXCL10 increase [24]
exacerbate progression of the disease by increased HLA
class I molecules and molecules involved in responding to
viruses such as MDA-5 [13] as well as furthered production
of CD8þ CD45RAþ CD45ROþ subset. Such mechanism may
disrupt the balance of cytotoxic subsets in enterovirus-
infected people with type 1 diabetes more severely than
in non-enterovirus-infected patients.
Genetic investigation of this disease is very complex as
the countries with high incidence of type 1 diabetes have
been reported to have the lower prevalence of enteroviral
infection than those with the low incidence of diabetes
type 1. In countries with low incidence of diabetes, this
finding may be due to the high prevalence of the genes
that have a role in cross reaction and molecular mimicry or
cause an excessive antiviral response. Undoubtedly,
further studies about the polymorphism of HLA class I al-
leles and MDA-5 as well as the presence of HLA-A*0201 and
HLA-DR4 can contribute greatly to detection of suscepti-
ble people.
Since autoantibodies, such as anti-GAD65, have been
demonstrated to be present even prior to the onset of the
disease, detection of susceptible people is conducted only
by detection of autoantibodies in serum. But, it is note-
worthy that in cases where viral causes are predisposing to
type 1 diabetes, measurement of autoantibodies alone does
not suffice to identify susceptible people. If the virus is
present in the body and takes the full replicative form to
reproduce, destruction of pancreatic beta cells occurs
without the presence of any autoantibodies or certain
immunological responses. In such cases, detection of sus-
ceptible people indeed may not be possible only through
measuring autoantibodies.Conclusion
According to the results of this study, it can be inferred that
in addition to the measurement of autoantibodies, espe-
cially the presence of anti-GAD65 in susceptible people’s
280 O. Zargari Samani et al.serum, other factors such as enteroviral infections, count-
ing the percentages of cytotoxic T cells and particularly
their effector (CD8þ CD45RAþCD45ROþ) subset and, for
advanced diagnosis, looking for HLA-A*0201 and HLA-DR4 or
detection increased CXCL10 mRNA can be used to detect
susceptible people. Our results suggested that enteroviral
infections had a direct relationship with type 1 diabetes
and enteroviruses caused pathogenesis in patients with
type 1diabetes possibly through inducing alterations in the
cellular distribution of various CTLs subsets. However, the
potential molecular mechanism by which enteroviruses can
disrupt the distribution balance of cytotoxic lymphocyte
subsets has not yet been known.
Further studies are needed to figure out the mechanisms
by which the enteroviruses develop diabetes, because if
the enterovirus can directly cause the destruction of beta
cells, enterovirus vaccine can be considered. In contrast, if
immunological cross-reactivity or exposure to autoantigens
by molecular mimicry mechanism causes inflammation,
autoimmune responses in diseases are exacerbated by
vaccination [13,25]. We reckoned that enteroviruses make
the alteration in CD8 T subsets in type 1 diabetic patients,
accordingly, we considered this alteration as one of a risk
factor in DM development. We think assessment CD8þ T
subsets in type 1 diabetic patients can be noted as a low
price-high sensitive screening test to recognition suscepti-
ble objects. Thus, the full understanding of the functional
mechanism of the virus in the pathogenesis of type 1 dia-
betes may lead to more effective diagnosis and treatment
strategies. To achieve this purpose, recognition of suscep-
tible people is the first step to take.Acknowledgement
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